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Abstract. The endotelio- and cardioprotective effects of vitamin B6 (2 mg/kg) and folic acid (0.2 
mg/kg) upon modeling of methionine-induced hyperhomocysteinemia via methionine intragastric 
administration at a dose of 3 g/kg were studied. It was shown that the combined use of vitamin B6 
and folic acid allows on the background of a significant reduction in homocysteine concentrations 
normalizing the endothelial dysfunction coefficient and the parameters of maximum left 
ventricular pressure in response to intravenous administration of adrenaline. 
The research was partially supported by the grant of the President of the Russian Federation 
№MD-4711.2015.7. 
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Introduction. By now, a number of factors of 
different nature has been determined [1], contributing to 
the development and progression of cardiovascular 
disease such as dyslipidemia, hypertension, overweight, 
smoking, physical inactivity, and diabetes. In addition, a 
group of so-called "new" risks can be distinguished, 
which primarily includes an increase in homocysteine 
levels in the blood. More than 80 clinical and 
epidemiological studies have confirmed that 
hyperhomocysteinemia is a significant, independent 
risk factors for early development and rapid progression 
of atherosclerosis, and thrombosis of the coronary, 
cerebral and peripheral arteries, and may be a predictor 
of death [2]. The obtained reliable evidences have 
served as the basis for creating homocysteic theory of 
pathogenesis of atherosclerosis development [3]. The 
first report on the role of homocysteine   as a possible 
risk factor for cardio-vascular diseases goes back to 
1964. S.H.Mudd, T.Gerritsen, H.A.Waismann et al. 
demonstrated that high concentration of homocysteine 
in the blood and, consequently, in urine, resulting in 
homocystinuria is a consequence of deficiency of the 
cystathionine-beta-synthase enzyme. 
Subject to the above, the objective of the study 
was to investigate the endotelio- and cardioprotective 
effects of vitamin B6 and folic acid upon modeling of 
methionine-induced hyperhomocysteinemia. 
Materials and methods. Experiments were 
conducted on white male Wistar rats weighing  
200-250 g. Hyperhomocysteinemia was simulated by 
intragastrical administration of methionine (JSC 
"Synthesis") at a dose of 3 g/kg/day for 7 days. 
Solution for intragastric administration of methionine 
was prepared ex tempore with polysorbate TWEEN-
80 and 1% starch solution. Data obtained by 
intragastric administration of an equivalent amount of 
polysorbate of 10% TWEEN-80 solution were used 
as control. Folic acid (Valenta Pharmaceuticals, 
OJSC) was administered intragastrically at a dose of 
0.2 mg/kg/day for 7 days. Vitamin B6 (Veropharm) 
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was administered intraperitoneally at a dose of  
2 mg/kg/day for 7 days.  
Animals were divided into groups (n=10): I – 
daily, once a day, for 7 days, intragastric 
administration of 10% Tween-80 solution at a dose 
of 1 ml/kg (control, n=10 animals); II - daily, once a 
day, intragastric administration of methionine at a 
dose of 3 g/kg for 7 days (n=10 animals); III - 
administration of folic acid on the background of 
methionine (0.2 mg/kg, intraperitoneally) and 
vitamin B6 (2 mg/kg, i.p.) once a day for 7 days. 
On day 8 of the experiment, a catheter was 
inserted under anesthetisia (chloral hydrate 300 
mg/kg) into the left carotid artery to record blood 
pressure (BP); bolus administration of 
pharmacological agents was into the femoral vein. 
Hemodynamic parameters: systolic blood pressure 
(SBP), diastolic blood pressure (DBP) and heart rate 
(HR) were measured continuously with the use of a 
sensor and the computer program “Biopac”. In 
addition to blood pressure measurements a series of 
functional tests was carried out in the following 
sequence: 1. Test for endothelium-dependent 
vascular relaxation (intravenous solution of 
acetylcholine (ACh) at a dose of 40 mg/kg at the rate 
of 0.1 ml per 100 g). 2. Test for endothelium-
independent vascular relaxation (intravenous solution 
of sodium nitroprusside (NP) at a dose of 30 mg/kg at 
the rate of 0.1 ml per 100 g) [4, 5, 6, 7, 8].  
The degree of endothelial dysfunction in 
experimental animal, as well as the degree of its 
correction with the studied medications was assessed by 
the estimated coefficient of endothelial dysfunction 
(EDC). The coefficient was calculated by the formula: 
EDC = BPS NP/ BPS AC, where BPS NP is an area of the 
triangle above the blood pressure recovery curve, where 
points of the smaller leg are the point of maximum 
blood pressure drop and the point of BP level egress to 
the plateau during the functional test with the 
administration of sodium nitroprusside, BPS AC - is an 
area of the triangle above the blood pressure recovery 
curve during the test with acetylcholine, where a 
smaller leg shall be the difference between the end point 
of bradycardiac cardiac component and a BP recovery 
point [6, 9, 10, 11, 12]. 
The development of hyperhomocysteinemia and 
its correction with the studied medications were 
assessed by the content of homocysteine in the blood 
serum of experimental animals. Homocysteine 
concentration was measured by immunoturbidimetric 
method with the use of a set by Pliva-Lachema 
Diagnostika s.r.o.     
To assess the myocardial functionality in 
animals under controlled respiration, the cavity of the 
left ventricle was catheterized and stress tests were 
performed in the following sequence: 
1. Test for adrenoreactivity (a one-time 
intravenous administration of epinephrine 
hydrochloride solution 1
 .
10
-5
 mol/L at the rate of  
0.1 ml per 100 g) [9, 10, 11]. During this test, the 
maximum increase in LVP in response to adrenaline 
administration was assessed. 
2. Resistance load (ascending aorta 
compression for 30 seconds) [1, 3]. After this test, 
index of myocardial reserve exhaustion was 
calculated (expressed as a percentage) equal to the 
ratio of increase in the LVP on the 5th second of 
compression to the increase in the LVP on the 25th 
second of compression. 
The significance of changes in absolute 
parameters was determined by the difference method 
of variation statistics with finding the average values   
of the shifts (M), the arithmetic mean (±m) and the 
probability of possible error (p) by using the Student 
tables. Differences were evaluated as significant at 
p<0.05. Statistical calculations were performed with 
Microsoft Excel 7.0. 
Results 
According to the study design, a 
hyperhomocysteinemia-induced endothelial 
dysfunction was simulated by daily intragastric 
administration of methionine at a dose of 3 g/kg for  
7 days.  
Intragastric administration of the stated dose of 
methionine resulted in a significant increase in the 
endothelial dysfunction coefficient up to 3.3 ± 0.3, 
while the EDC in the control group was 0.9 ± 0.2. 
Systolic and diastolic blood pressure values remained 
within physiological limits in all series of the 
experiments (Table 1). 
Simultaneous administration of methionine, 
vitamin B6 and folic acid led to a significant 
reduction in EDC up to 1.7 ± 0.1 (Table 1). 
Table 1 
Effect of vitamin B6 and folic acid on functional  
and biochemical parameters of rats in modeling 
 the endothelial dysfunction by intraperitoneal 
administration of nitro-L-arginine methyl ester  
(L-NAME) at a dose of 25 mg/kg (M ±m, n=10) 
 
Groups of animals 
SBP, mm 
Hg 
DBP, mm 
Hg 
EDC, c.u. 
Control 
10% TVIN-80 
129.2 ±4.3 82.4 ± 5.9 0.9±0.2 
Methionine 3 g/kg 118.9±10.1 76.6±7.2 3.3±0.3* 
Methionine + folic 
acid + vitamin В6 
121.4±5.6 82.6±6.1* 1.7±0.1** 
 
Note: SBP – systolic blood pressure; DBP – diastolic 
blood pressure; EDC – endothelial dysfunction coefficient; 
*– at p<0.05 as compared to control animals; **– at 
p<0.05 as compared to group receiving Methionine. 
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The results of the study of homocysteine 
concentration in the blood serum of experimental 
animals are shown in Table 2. Intragastric 
administration of methionine resulted in significant 
increase in the concentration of homocysteine, while 
co-administration of vitamin B6 and folic acid allowed 
significantly reducing this coefficient and making it 
closer to the values of the control group (Table 2).  
Table 2 
Effect of vitamin B6 and folic acid on homocysteine 
concentration in the blood serum of experimental 
animals  (М±m, n=10) 
 
Groups of 
animals 
Control Methionine 
Methionine 
+ folic acid 
+ vitamin В6 
Homocysteine 
concentration 
(mkmol/l) 
8.6±1.4 53.5±8.1* 24.3±4.6** 
 
Note: *- at p<0.05 as compared to control 
animals; **- at p<0.05 as compared to group receiving 
Methionine. 
 
During test for adrenoreactivity, the group of 
animals, which received intragastrically vitamin B6 
and folic acid on the background of methionine, 
showed a decrease in the absolute values of left 
ventricular pressure, which indicates the prevention 
of hyperhomocystein-induced increase of 
adrenoreactivity (Table 3). 
During test for resistance load, neither vitamin 
B6 nor folic acid prevented the drop of contractility 
in the period from 5 to 25 second of aortic 
compression. For example, index of myocardial 
reserve exhaustion on the 25th second of the test was 
85.4±3.1% in the control group. The same in the 
methionine-treated animals was 69.8±3.4%. Results 
in the group of animals treated with vitamin B6 and 
folic acid were equal to 72.4±4.1% (Table 3). 
Table 3 
Effect of vitamin B6 and folic acid on the contractile 
parameters of the left ventricle of rats during stress 
testing (M±m, n=10) 
 
Group of animals 
Adrenoreactivity 
(LVP, mm Hg) 
Aortic 
compression 
(%) 
Control 189.7±9.1 85.4±3.1 
Methionine 238.1±3.4* 69.8±3.4* 
Methionine + folic 
acid + vitamin В6 
217.9±4.8**
 72.4±4.1* 
 
Note: *- at p<0.05 as compared to control animals; 
**- at p<0.05 as compared to group receiving Methionine. 
 
Discussion. Possible role of homocysteine (HC) 
in the development of cardiovascular diseases (CVD) 
started to be investigated after K. McCully 
demonstrated in 1969 a predisposition to 
atherothrombotic events in patients with severe 
hyperhomocysteinemia (HHC) (HC> 100 µmol/l). 
The mechanism of development of atherosclerotic 
vascular lesions with hyperhomocysteinemia remains 
unclear. Experimental findings suggest that the 
products of homocysteine autoxidation proceeding 
with the formation of reactive oxygen species induce 
the formation of atherosclerotic plaques by damaging 
endothelium, destroying the integrity of the vascular 
wall and stimulating the proliferation of medial 
smooth muscle cells [2, 3]. Homocysteine also 
impairs the normal NO production by endothelial 
cells, reduces the bioavailability of NO by decreasing 
its synthesis. Increased lipid peroxidation with 
homocysteine involvement leads both to a reduction 
in NO production by the NO-synthase enzyme, and 
to NO direct degradation.  
The literature provides evidences that the use of 
vitamin B6 and folic acid can effectively reduce 
homocysteine levels [2]. In our study, the use of 
therapeutic doses of vitamin B6 and folic acid 
allowed normalizing the ratio of endothelium-
dependent and endothelium-independent vasodilation 
with a significant decrease in the endothelial 
dysfunction coefficient. During stress testing, 
intragastric administration of vitamin B6 and folic 
acid on the background of methionine allowed 
reducing the adrenoreactivity in the experiment with 
an open heart, however, has not resulted in the 
prevention of myocardial reserve exhaustion. Positive 
dynamics of functional performance was 
accompanied by a significant decrease in the 
concentration of homocysteine.  
These facts confirm the important role of vitamin 
B6 and folic acid in the implementation of the 
protective effect in case of hyperhomocysteinemy, 
however, raise the question of the possibility of their 
combined application with conventional drugs used to 
treat cardiovascular disease (ATE inhibitors, AT-I 
receptor blockers, etc.).  
Conclusions. 
1. Combined application of vitamin B6 at a dose 
of 2 mg/kg and folic acid at a dose of 0.2 mg/kg has 
endothelioprotective effect shown in the model of 
methionine-induced hyperhomocysteinemia.  
2. Combined application of vitamin B6 at a dose 
of 2 mg/kg and folic acid at a dose of 0.2 mg/kg on 
the background of simulated methionine-induced 
hyperhomocysteinemia reduces the maximum 
pressure in the cavity of the left ventricle during test 
for adrenoreactivity and has no effect on the 
myocardial reserve exhaustion during the test for 
resistance load. 
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